Microbiological effects of consuming a synbiotic containing Bifidobacterium bifidum, Bifidobacterium lactis, and oligofructose in elderly persons, determined by real-time polymerase chain reaction and counting of viable bacteria

被引:129
作者
Bartosch, S [1 ]
Woodmansey, EJ
Paterson, JCM
McMurdo, MET
Macfarlane, GT
机构
[1] Univ Dundee, Ninewells Hosp & Med Sch, Microbiol & Gut Biol Grp, Dundee DD1 9SY, Scotland
[2] Univ Dundee, Sect Ageing & Hlth, Dundee DD1 4HN, Scotland
关键词
D O I
10.1086/426027
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Because of changes in gut physiology, immune system reactivity, and diet, elderly people are more susceptible to gastrointestinal infections than are younger adults. The gut microflora, which provides a natural defense against invading microorganisms, changes in elderly people with the development of potentially damaging bacterial populations, which may lead to alterations in bacterial metabolism and higher levels of infection. Methods. A randomized, double- blind, controlled feeding trial was done with 18 healthy elderly volunteers ( age, >62 years) using a synbiotic comprising Bifidobacterium bifidum BB- 02 and Bifidobacterium lactis BL- 01 ( probiotics) together with an inulin- based prebiotic ( Synergy 1; Orafti). Real- time PCR was employed to quantitate total bifidobacteria, B. bifidum, and B. lactis in fecal DNA before, during, and after synbiotic consumption. Counting all viable anaerobes, bifidobacteria, and lactobacilli and identification of bacterial isolates to species level was also done. Results. Throughout feeding, both bifidobacteria species were detected in fecal samples obtained from all subjects receiving the synbiotic, with significant increases in the number of copies of the 16S rRNA genes of B. bifidum, B. lactis, and total bifidobacteria, compared with the control week and the placebo group. At least 1 of these species remained detectable in fecal samples 3 weeks after feeding in individuals that had no fecal B. bifidum and/or B. lactis in the control week, indicating that the probiotics persisted in the volunteers. Counting of viable organisms showed significantly higher total numbers of fecal bifidobacteria, total numbers of lactobacilli, and numbers of B. bifidum during synbiotic feeding. Conclusion. Synbiotic consumption increased the size and diversity of protective fecal bifidobacterial populations, which are often very much reduced in older people.
引用
收藏
页码:28 / 37
页数:10
相关论文
共 39 条
[1]   Effect of galacto-oligosaccharide supplementation on human faecal microflora and on survival and persistence of Bifidobacterium lactis Bb-12 in the gastrointestinal tract [J].
Alander, M ;
Mättö, J ;
Kneifel, W ;
Johansson, M ;
Kögler, B ;
Crittenden, R ;
Mattila-Sandholm, T ;
Saarela, M .
INTERNATIONAL DAIRY JOURNAL, 2001, 11 (10) :817-825
[2]   Characterization of bacterial communities in feces from healthy elderly volunteers and hospitalized elderly patients by using real-time PCR and effects of antibiotic treatment on the fecal microbiota [J].
Bartosch, S ;
Fite, A ;
Macfarlane, GT ;
McMurdo, MET .
APPLIED AND ENVIRONMENTAL MICROBIOLOGY, 2004, 70 (06) :3575-3581
[3]   AN ELECTIVE AND SELECTIVE ISOLATION MEDIUM FOR BIFIDOBACTERIUM SPP [J].
BEERENS, H .
LETTERS IN APPLIED MICROBIOLOGY, 1990, 11 (03) :155-157
[4]   Identification of nonpoint sources of fecal pollution in coastal waters by using host-specific 16S ribosomal DNA genetic markers from fecal anaerobes [J].
Bernhard, AE ;
Field, KG .
APPLIED AND ENVIRONMENTAL MICROBIOLOGY, 2000, 66 (04) :1587-1594
[5]   STABILITY OF HUMAN FECAL FLORA [J].
BORNSIDE, GH .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 1978, 31 (10) :S141-S144
[6]  
Bouhnik Y, 1996, EUR J CLIN NUTR, V50, P269
[7]   FECAL RECOVERY IN HUMANS OF VIABLE BIFIDOBACTERIUM SP INGESTED IN FERMENTED MILK [J].
BOUHNIK, Y ;
POCHART, P ;
MARTEAU, P ;
ARLET, G ;
GODEREL, I ;
RAMBAUD, JC .
GASTROENTEROLOGY, 1992, 102 (03) :875-878
[8]   Specific detection of Bifidobacterium strains in a pharmaceutical probiotic product and in human feces by polymerase chain reaction [J].
Brigidi, P ;
Vitali, B ;
Swennen, E ;
Altomare, L ;
Rossi, M ;
Matteuzzi, D .
SYSTEMATIC AND APPLIED MICROBIOLOGY, 2000, 23 (03) :391-399
[9]   Persistence of colonization of intestinal mucosa by a Probiotic strain, Lactobacillus casei subsp rhamnosus Lcr35, after oral consumption [J].
De Champs, C ;
Maroncle, N ;
Balestrino, D ;
Rich, C ;
Forestier, C .
JOURNAL OF CLINICAL MICROBIOLOGY, 2003, 41 (03) :1270-1273
[10]   Biotherapeutic agents in the treatment of infectious diarrhea [J].
Elmer, GW ;
McFarland, LV .
GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2001, 30 (03) :837-+